戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 e release by a distantly related retrovirus, Mason-Pfizer monkey virus.
2 otein that interacts with the Gag protein of Mason-Pfizer monkey virus.
3 targeting and retention signal CTRS found in Mason-Pfizer monkey virus and that FV Gag has the inhere
4 ntracellular capsid transport and release of Mason-Pfizer monkey virus are dependent on myristylation
5 bly and release of murine leukemia virus and Mason-Pfizer monkey virus are insensitive to TSG-5'.
6 g of Gag protein shells-immature capsids--of Mason-Pfizer monkey virus assembled in Escherichia coli
7  A transcriptional enhancer element from the Mason-Pfizer monkey virus can override the silencing and
8 wever, the constitutive transport element of Mason-Pfizer monkey virus can substitute for RRE and Rev
9              Tap interacts directly with the Mason-Pfizer monkey virus constitutive transport element
10 nclusion of cis-acting elements, such as the Mason-Pfizer monkey virus constitutive transport element
11 the nuclear export of mRNAs that contain the Mason-Pfizer monkey virus constitutive transport element
12 sm by either Rev/Rev response element or the Mason-Pfizer monkey virus constitutive transport element
13 trast, DeltaCAN had no significant affect on Mason-Pfizer monkey virus constitutive transport element
14                 The transmembrane protein of Mason-Pfizer monkey virus contains two heptad repeats th
15  RNA comprised almost entirely of the CTE of Mason-Pfizer monkey virus (CTE RNA) is exported efficien
16 ssion of unspliced RNA containing either the Mason-Pfizer monkey virus-CTE or the recently discovered
17 plasma membrane assembly, PPPY L domain) and Mason-Pfizer monkey virus (cytoplasmic assembly, PPPY L
18 itutive transport element (CTE) derived from Mason-Pfizer monkey virus for expression of the viral pr
19                Unlike most retroviruses, the Mason-Pfizer monkey virus Gag polyproteins assemble into
20                                    SRV-2 and Mason-Pfizer monkey virus have highly homologous element
21 ent is different from that seen in HIV-1 and Mason-Pfizer monkey virus, illustrating further structur
22 scribe a unique experimental system in which Mason-Pfizer monkey virus immature capsids are removed f
23                                              Mason-Pfizer monkey virus immature capsids selected from
24 avian sarcoma virus IN, rather than HIV-1 or Mason-Pfizer monkey virus IN, were substituted into the
25 4 and pp16 proteins of the type D retrovirus Mason-Pfizer monkey virus (M-PMV) are phosphoproteins th
26 an immunodeficiency virus type 1 (HIV-1) and Mason-Pfizer monkey virus (M-PMV) but not Moloney murine
27                                              Mason-Pfizer monkey virus (M-PMV) capsids that have asse
28                                              Mason-Pfizer monkey virus (M-PMV) encodes a transmembran
29                                              Mason-Pfizer monkey virus (M-PMV) encodes a transmembran
30                The matrix (MA) domain of the Mason-Pfizer monkey virus (M-PMV) Gag polyprotein plays
31         High Five cells expressing wild-type Mason-Pfizer monkey virus (M-PMV) Gag precursors accumul
32                                          The Mason-Pfizer monkey virus (M-PMV) Gag protein possesses
33 ag-derived protein of the related retrovirus Mason-Pfizer monkey virus (M-PMV) has previously been re
34 he CA C-terminal domains (CTDs) of HIV-1 and Mason-Pfizer monkey virus (M-PMV) highlighted a spacer-l
35                                              Mason-Pfizer monkey virus (M-PMV) is a prototypical beta
36                                          The Mason-Pfizer monkey virus (M-PMV) is the prototype of th
37 1) as a cellular factor regulating HIV-1 and Mason-Pfizer monkey virus (M-PMV) particle release.
38 lock glycoprotein incorporation into budding Mason-Pfizer monkey virus (M-PMV) particles and abrogate
39         We explored how a simple retrovirus, Mason-Pfizer monkey virus (M-PMV) to facilitate its repl
40  the structures and membrane affinity of the Mason-Pfizer monkey virus (M-PMV) wild-type MA with its
41        We sought to determine whether or not Mason-Pfizer monkey virus (M-PMV), a prototype betaretro
42   In contrast, several retroviruses, such as Mason-Pfizer monkey virus (M-PMV), assemble in the cytop
43 psids of the prototypical type D retrovirus, Mason-Pfizer monkey virus (M-PMV), can assemble in a cel
44 thin the assembled Gag lattices of HIV-1 and Mason-Pfizer monkey virus (M-PMV), the C-terminal domain
45                                              Mason-Pfizer monkey virus (M-PMV), the prototype type D
46                                              Mason-Pfizer monkey virus (M-PMV), the prototypical type
47               "Simple" retroviruses, such as Mason-Pfizer monkey virus (MPMV) and murine leukemia vir
48 ing either a Rev response element (RRE) or a Mason-Pfizer monkey virus (MPMV) constitutive transport
49 onal regulatory element (PRE)-containing and Mason-Pfizer monkey virus (MPMV) constitutive transport
50  and env expression vectors that contain the Mason-Pfizer monkey virus (MPMV) constitutive transport
51 ow that the genome of the simpler retrovirus Mason-Pfizer monkey virus (MPMV) contains an element tha
52 me that the 5' long terminal repeat (LTR) of Mason-Pfizer monkey virus (MPMV) facilitates Rev/Rev-res
53                    Here, we demonstrate that Mason-Pfizer monkey virus (MPMV) is resistant to inhibit
54 s well as a nonlentiviral retrovirus such as Mason-Pfizer monkey virus (MPMV), and vice versa.
55  the constitutive transport element (CTE) of Mason-Pfizer monkey virus (MPMV), or the pre-mRNA proces
56 an association of KIF-4 with Gag proteins of Mason-Pfizer monkey virus (MPMV), simian immunodeficienc
57 he constitutive transport element (CTE) from Mason-Pfizer monkey virus (MPMV).
58 ype 1 (HIV-1), Rous sarcoma virus (RSV), and Mason-Pfizer monkey virus (MPMV)] and discuss structural
59 d recently in the distal zinc knuckle of the Mason-Pfizer monkey virus nucleocapsid protein.
60                                 For example, Mason-Pfizer monkey virus overcomes cellular restriction
61 clear export of RNA transcripts derived from Mason-Pfizer monkey virus that contain the constitutive
62                                           In Mason-Pfizer monkey virus, the required RNA sequence ele
63  separates the CA and NC domains, whereas in Mason-Pfizer monkey virus, this region is densely packed
64 roviruses (HIV-1, murine leukemia virus, and Mason-Pfizer monkey virus), two hepadnaviruses (hepatiti
65 SCRT-I was required for efficient release of Mason-Pfizer monkey virus, which buds primarily by using